Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pinpoint Science is a San Francisco-based biotechnology company developing a bioelectronic point-of-care diagnostic platform designed for rapid pathogen detection. The company's core technology utilizes novel nanosensors and swappable cartridges to detect specific biomarkers of viral, bacterial, and fungal infections directly from biofluids like saliva or blood. By providing lab-quality results in under a minute, the platform aims to transform disease surveillance and clinical diagnosis for conditions such as COVID-19, influenza, and mosquito-borne illnesses. Pinpoint Science collaborates with major semiconductor partners like Analog Devices to scale its high-sensitivity, low-cost diagnostic solutions. The company is positioned to address global health threats through decentralized, real-time screening and monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pinpoint Sciences.